Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The 2019 novel coronavirus (2019-nCoV) infection caused clusters of severe respiratory illness similar to SARS and was associated with ICU admission and high mortality. There is no confirmed antivirus therapy for people infected 2019-nCoV, most of them should receive supportive care to help relieve symptoms. This clinical trial is to evaluate the effect of Fuzheng Huayu tablet on lung inflammation in intensive patients with novel coronavirus pneumonia and reduce the progressive rate to critical type.
Description: Evaluation of the therapeutic effect of Fuzheng huayu tablet
Measure: the percentage of patients showing improvement in chest CT Time: Week 2Description: Evaluation of pulmonary inflammation improvement
Measure: remission rate or progression rate of critical illness Time: Week 2Description: Evaluation of pulmonary inflammation improvement
Measure: clinical remission rate of respiratory symptoms Time: week 2Description: Evaluation of pulmonary inflammation improvement
Measure: routine blood examination Time: Week 2Description: Evaluation of the therapeutic effect of Fuzheng huayu tablet
Measure: C-reactive protein level Time: Week 2Description: Evaluation of pulmonary inflammation improvement
Measure: procalcitonin level Time: Week 2Description: Evaluation of pulmonary inflammation improvement
Measure: oxygen saturation Time: Week 2Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports